Patent · US Active

Compositions and methods for inhibiting CD73

US12331068B2 · kind B2 · utility

0Cited by
1References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 31, 2019
Grant dateJun 17, 2025
Priority date
Expiry dateOct 28, 2042

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/505
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds that modulate CD73 activity, pharmaceutical compositions containing these compounds, and methods of using these compounds for treating diseases associated with CD73 activity are described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.